Skip to content

A randomized controlled trial of 650nm low intensity red light in the prevention and control of myopia

A clinical study on the effects of environmental factors, red light regulation and physical intervention on myopia prevention and control based on large-sample cohort observations and multi-center randomized controlled trials - Rearch on myopia control using read-light

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058963
Enrollment
Unknown
Registered
2022-04-20
Start date
2021-08-12
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Sponsors

Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 6 to 12 years; 2. The diopter range of both eyes is -6D<= spherical lens <=3D, and cylindrical lens <=2.50D; 3. The guardian of the child can understand the study protocol and is willing to participate in the study, and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have had myopia surgery and used low-concentration atropine eye drops or orthokeratoscope for myopia control; 2. Patients with anisometropia (two eyes with diopter difference >1.50D), strabismus and amblyopia; 3. Secondary myopia (patients with congenital eye lesions or systemic syndromes, such as congenital cataract, congenital retinal disease, retinopathy of prematurity), or myopia with systemic syndromes (such as Marfan syndrome); 4. Refractive media turbidity (keratopathy, lens turbidity, etc.); 5. Fundus lesions, optic neuropathy or other inner eye diseases.

Design outcomes

Primary

MeasureTime frame
Axial length;Spherical refractive error;

Countries

China

Contacts

Public ContactJie Ying

Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University

jie_yingcn@aliyun.com+86 13810146899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026